Scan to Download
One power score. Smarter investment decisions
Edgewise Therapeutics Inc
EWTX22.670USD
+0.420+1.89%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
2.40BMarket Cap
LossP/E TTM
Edgewise Therapeutics Inc
22.670
+0.420+1.89%
You can find the annual or quarterly income statement of Edgewise Therapeutics Inc here for insights into the performance and operational efficiency of Edgewise Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
15.89%46.86M
11.82%42.61M
32.24%45.96M
34.49%45.54M
37.28%40.43M
50.39%38.11M
35.20%34.75M
53.37%33.86M
61.27%29.45M
53.65%25.34M
73.37%25.70M
72.20%22.08M
39.66%18.26M
57.66%16.49M
116.22%14.83M
102.11%12.82M
258.93%13.08M
164.34%10.46M
111.11%6.86M
--6.34M
--3.64M
--3.96M
--3.25M
R&D expenses
16.32%37.48M
9.38%33.56M
32.73%36.76M
31.38%36.37M
35.47%32.22M
56.86%30.68M
39.33%27.69M
66.65%27.68M
71.20%23.79M
57.71%19.56M
78.68%19.88M
82.79%16.61M
40.63%13.89M
57.77%12.40M
107.54%11.12M
76.84%9.09M
205.13%9.88M
116.02%7.86M
80.65%5.36M
--5.14M
--3.24M
--3.64M
--2.97M
Depreciation, depletion, and amortization
-2.97%523.00K
8.96%523.00K
17.12%554.00K
30.23%629.00K
20.04%539.00K
13.21%480.00K
142.56%473.00K
448.86%483.00K
349.00%449.00K
337.11%424.00K
134.94%195.00K
12.82%88.00K
56.25%100.00K
90.20%97.00K
5.06%83.00K
56.00%78.00K
28.00%64.00K
13.33%51.00K
97.50%79.00K
--50.00K
--50.00K
--45.00K
--40.00K
Operating profit
-15.89%-46.86M
-11.82%-42.61M
-32.24%-45.96M
-34.49%-45.54M
-37.28%-40.43M
-50.39%-38.11M
-35.20%-34.75M
-53.37%-33.86M
-61.27%-29.45M
-53.65%-25.34M
-73.37%-25.70M
-72.20%-22.08M
-39.66%-18.26M
-57.66%-16.49M
-116.22%-14.83M
-102.11%-12.82M
-258.93%-13.08M
-164.34%-10.46M
-111.11%-6.86M
---6.34M
---3.64M
---3.96M
---3.25M
Net non-operating interest income (expenses)
Non-operating interest income
-1.76%6.19M
-1.74%6.50M
-17.13%5.16M
58.05%5.88M
68.57%6.30M
70.80%6.61M
117.31%6.23M
39.60%3.72M
389.40%3.74M
812.74%3.87M
1626.51%2.87M
2014.29%2.66M
501.57%764.00K
296.26%424.00K
295.24%166.00K
6200.00%126.00K
12600.00%127.00K
3466.67%107.00K
-33.33%42.00K
--2.00K
--1.00K
--3.00K
--63.00K
Income before tax
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
-113.97%-6.81M
---6.34M
---3.64M
---3.95M
---3.19M
Income tax
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
-113.97%-6.81M
---6.34M
---3.64M
---3.95M
---3.19M
Net income from continuous operations
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
-113.97%-6.81M
---6.34M
---3.64M
---3.95M
---3.19M
Net income attributable to controlling interests
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
-113.97%-6.81M
---6.34M
---3.64M
---3.95M
---3.19M
Net income attributable to common shareholders
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
-113.97%-6.81M
---6.34M
---3.64M
---3.95M
---3.19M
Basic earnings per share
-5.96%-0.39
-2.18%-0.34
-31.66%-0.43
10.02%-0.42
10.21%-0.36
0.57%-0.34
9.76%-0.33
-51.79%-0.47
-20.05%-0.41
-4.62%-0.34
-21.99%-0.36
-19.50%-0.31
-28.41%-0.34
-54.05%-0.32
-106.53%-0.30
-92.38%-0.26
-243.27%-0.26
-152.86%-0.21
-113.96%-0.14
---0.13
---0.08
---0.08
---0.07
Diluted earnings per share
-5.96%-0.39
-2.18%-0.34
-31.66%-0.43
10.02%-0.42
10.21%-0.36
0.57%-0.34
9.76%-0.33
-51.79%-0.47
-20.05%-0.41
-4.62%-0.34
-21.99%-0.36
-19.50%-0.31
-28.41%-0.34
-54.05%-0.32
-106.53%-0.30
-92.38%-0.26
-243.27%-0.26
-152.86%-0.21
-113.96%-0.14
---0.13
---0.08
---0.08
---0.07
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
